Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells

F L Chang1, Y F Ling, M D Lai

  • 1Department of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.

Anticancer Research
|April 19, 2000
PubMed
Abstract

Insights

The tumor suppressor gene p53 enhances cisplatin-induced apoptosis in bladder cancer cells. Even without mutant p53 expression, wild-type p53 stabilization increases cancer cell sensitivity to chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The role of tumor suppressor gene p53 in bladder cancer cell apoptosis remains unclear.
  • Investigating the necessity of p53 for cisplatin-induced apoptosis in human bladder cancer cell line TSGH-8301.

Purpose of the Study:

  • To determine the role of wild-type p53 in mediating apoptosis.
  • To understand the effect of mutant p53 expression on bladder cancer cell sensitivity to cisplatin.

Main Methods:

  • TSGH-8301 cells with wild-type p53 were transfected with mutated p53 cDNA.
  • Stable transfectants were confirmed using Southern and Western blotting.
  • Cellular response to cisplatin was assessed via viability, DNA fragmentation, and nuclear condensation assays.

Main Results:

  • Cells with exogenous mutant p53 showed increased cisplatin sensitivity and apoptosis.
  • No significant difference in sensitivity was observed in clones with rearranged or undetectable mutant p53.
  • RT-PCR sequencing revealed no exogenous mutant p53 mRNA expression in transfectants.

Conclusions:

  • Transfectants lost mutant p53 expression but enhanced wild-type p53 expression, conferring cisplatin sensitivity.
  • Transient mutant p53 expression may lead to irreversible p53 stabilization and increased steady-state p53 levels.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...